Global Cannabis News & Analysis | Business of Cannabis
Grow Group has announced the completion of a recapitalisation, has appointed Co-CEOs, and now expects to generate healthy EBITDA in 2027.
Brains Bioceutical Corp. has announced plans to list on Nasdaq, in what would be the first US public-market debut for a UK-based cannabinoid pharma manufacturer since GW Pharmaceuticals was acquired by Jazz in 2021.
An Irish government-backed enterprise fund has, for the first time in its 10-year history, named a cannabis company its High Potential Start-up (HPSU) Founder of the Year award.
The Council of the European Union has adopted proposals that would see the whole hemp plant, including inflorescences and leaves, recognised as an ordinary agricultural product.
SynBiotic SE, once one of the largest and most promising cannabis companies in Germany, has announced plans to file for insolvency and had its shares suspended on the Xetra and Frankfurt stock exchanges.
Medical cannabis’s cultivar names have, over the past two years, become an increasingly controversial part of the European prescription framework.
Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU.
UK medical cannabis patients have been told that they’ll have access to a six-month stockpile of Bedrolite, following weeks of uncertainty in the wake of Bedrocan’s collapse.
A Michigan cultivator is fighting to overturn a landmark court decision which has thrown the enforceability of cannabis industry contracts across the US into question.
